Therapeutic plasma exchange in the management of sepsis and multiple organ dysfunction syndrome: A report of three cases

Journal of Clinical Apheresis

Volumn 29, Issue 2, 2014, Pages 127-131

  De Simone, Nicole ^a   Racsa, Lori ^a   Bevan, Scott ^a   Matevosyan, Karén ^a   Valley, Thomas ^a   Girod, Carlos ^a   Sarode, Ravi ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

coagulopathy; fresh frozen plasma; multiple organ dysfunction syndrome; sepsis; therapeutic plasma exchange

Indexed keywords

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; CASE REPORT; CHILD; DISEASE COURSE; FEMALE; HUMAN; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIPLE ORGAN FAILURE; PLASMAPHERESIS; PRESCHOOL CHILD; SEPSIS; TREATMENT OUTCOME; IMMUNOLOGY; MIDDLE AGED;

ADULT; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PLASMA EXCHANGE; SEPSIS;

EID: 84899114377     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.21296     Document Type: Article

References (32)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR,. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303-1310.
2. Wheeler AP, Bernard GR,. Treating patients with severe sepsis. New England J Med 1999; 340: 207-214.
3. Martin GS, Mannino DM, Eaton S, Moss M,. The epidemiology of sepsis in the United States from 1979 through 2000. New England J Med 2003; 348: 1546-1554.
4. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ,. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-1655.
5. Hotchkiss RS, Karl IE,. The pathophysiology and treatment of sepsis. New England J Med 2003; 348: 138-150.
6. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG,. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22: 707-710.
7. Doughty LA, Kaplan SS, Carcillo JA,. Inflammatory cytokine and nitric oxide responses in pediatric sepsis and organ failure. Critical Care Med 1996; 24: 1137-1143.
8. Zimmerman JE, Kramer AA, McNair DS, Malila FM,. Acute Physiology and Chronic Health Evaluation (APACHE) IV: hospital mortality assessment for today's critically ill patients. Crit Care Med 2006; 34: 1297-1310.
9. Fisher CJ Jr., Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff JC, Abraham E, Schein RM, Benjamin E., Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. New England J Med 1996; 334: 1697-1702.
10. Abraham E, Wunderink R, Silverman H, Perl TM, Nasraway S, Levy H, Bone R, Wenzel RP, Balk R, Allred R,. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. JAMA 1995; 273: 934-941.
11. Fisher CJ Jr., Slotman GJ, Opal SM, Pribble JP, Bone RC, Emmanuel G, Ng D, Bloedow DC, Catalano MA., Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. Crit Care Med 1994; 22: 12-21.
12. Marshall JC,. Clinical trials of mediator-directed therapy in sepsis: what have we learned? Intensive Care Med 2000; 26: S75-S83.
13. Stegmayr BG,. Apheresis as therapy for patients with severe sepsis and multiorgan dysfunction syndrome. Therapeutic Apheresis 2001; 5: 123-127.
14. Stegmayr B,. Apheresis in patients with severe sepsis and multi organ dysfunction syndrome. Transfusion Apheresis Science 2008; 38: 203-208.
15. Stegmayr BG,. A survey of blood purification techniques. Transfusion Apheresis Sci 2005; 32: 209-220.
16. Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Weinstein R, Shaz BH,. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apheresis 2010; 25: 83-177.
17. Benoit M, Desnues B, Mege J-L,. Macrophage polarization in bacterial infections. J Immunol (Baltimore, Md.: 1950) 2008; 181: 3733-3739.
18. Lolis E, Bucala R,. Therapeutic approaches to innate immunity: severe sepsis and septic shock. Nature reviews. Drug Dis 2003; 2: 635-645.
19. Levi M, van der Poll T, ten Cate H,. Tissue factor in infection and severe inflammation. Semin Thrombosis Hemostasis 2006; 32: 33-39.
20. Peters K, Unger RE, Brunner J, Kirkpatrick CJ,. Molecular basis of endothelial dysfunction in sepsis. Cardiovascular Res 2003; 60: 49-57.
21. Levi M, van der Poll T, Büller HR,. Bidirectional relation between inflammation and coagulation. Circulation 2004; 109: 2698-2704.
22. van der Poll T, Levi M, Büller HR, van Deventer SJ, de Boer JP, Hack CE, ten Cate JW,. Fibrinolytic response to tumor necrosis factor in healthy subjects. J Exp Med 1991; 174: 729-732.
23. Levi M, van der Poll T,. Inflammation and coagulation. Crit Care Med 2010; 38 (2 Suppl): S26-S34.
24. Ely EW, Kleinpell RM, Goyette RE,. Advances in the understanding of clinical manifestations and therapy of severe sepsis: an update for critical care nurses. Am J Crit Care 2003; 12: 120-133; quiz 134-135.
25. Nakae H, Yonekawa T, Narita K, Endo S,. Are proinflammatory cytokine concentrations reduced by plasma exchange in patients with severe acute hepatic failure? Res Commun Mol Pathol Pharmacol 2001; 109 (1-2): 65-72.
26. Martí-Carvajal AJ, Solà I, Lathyris D, Cardona AF,. Human recombinant activated protein C for severe sepsis. Cochrane database of systematic reviews (Online). 2012; 3: CD004388.
27. Qu L, Kiss JE, Dargo G, Carcillo JA,. Outcomes of previously healthy pediatric patients with fulminant sepsis-induced multisystem organ failure receiving therapeutic plasma exchange. J Clin Apheresis 2011; 26: 208-213.
28. Stegmayr BG, Banga R, Berggren L, Norda R, Rydvall A, Vikerfors T,. Plasma exchange as rescue therapy in multiple organ failure including acute renal failure. Crit Care Med 2003; 31: 1730-1736.
29. Reeves JH, Butt WW, Shann F, Layton JE, Stewart A, Waring PM, Presneill JJ,. Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group. Crit Care Med 1999; 27: 2096-2104.
30. Busund R, Koukline V, Utrobin U, Nedashkovsky E,. Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial. Intensive Care Med 2002; 28: 1434-1439.
31. Nguyen TC, Han YY, Kiss JE, Hall MW, Hassett AC, Jaffe R, Orr RA, Janosky J, Carcillo JA,. Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure. Critical Care Med 2008; 36: 2878-2887.
32. van Deuren M, Brandtzaeg P, van der Meer JW,. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 2000; 13: 144-166, table of contents.